U.S. Health Care REITs Stock News

Fresh IPOs are back in the spotlight, with the record SpaceX listing, a 19.2% first day surge, talk of Middle East peace helping crude oil prices, and stronger consumer sentiment all hitting the market at once. At the same time, stubborn inflation and a Federal Reserve that looks set to hold rates steady keep a lid on the easy-money story. Against this mix, some newly listed stocks have started to stand out. This article highlights 3 recent IPOs from the IPO Momentum Stocks screener. These...

Box (BOX) is back in focus after recent trading left the stock down about 29% over the past year, while the company still reports annual revenue of US$1.21b and net income of US$95.45m. See our latest analysis for Box. Recent trading tells a mixed story, with the 30 day share price return of 2.92% and 90 day share price return of 4.27% set against a year to date share price decline of 11.93% and a 1 year total shareholder return decline of 28.62%. This pattern suggests momentum has been...

Kennedy-Wilson Holdings (KW) has attracted fresh attention after recent trading, with the stock last closing at $10.93. For investors, that price stands in the context of mixed recent returns and sizeable exposure to global real estate. See our latest analysis for Kennedy-Wilson Holdings. Recent trading has been relatively muted, with a 1 day share price return of 0.09% and a 30 day share price return of 0.91%. However, a 13.38% year to date share price return sits alongside a 1 year total...

Earlier this week, D.R. Horton drew attention by securing multi-year construction cost contracts and placing a very large order for grass-based structural panels from startup Planted, founded by former SpaceX engineers. The combination of cost protection and an experimental move into alternative building materials highlights how D.R. Horton is seeking both efficiency and more sustainable construction options. We'll now examine how D.R. Horton's cost shields and innovative materials...

Mercury General (MCY) has caught investor attention after reporting a profit rebound in Q1 2026 and securing a positive shift in analyst sentiment, including upward revisions to earnings estimates and favorable momentum scores. See our latest analysis for Mercury General. The stock’s recent 11.6% 90 day share price return and 58.8% one year total shareholder return suggest momentum is building, with the Q1 profit rebound and fresh fixed income offering helping reset investor expectations...

Some The J. M. Smucker Company ( NYSE:SJM ) shareholders may be a little concerned to see that the Chief Legal Officer...

Chord Energy (CHRD) has been pulled into wider market tension as geopolitical risks in the Middle East, including conflicting headlines around a potential US Iran deal and incidents involving US military assets, ripple through energy stocks. See our latest analysis for Chord Energy. Beyond the latest headlines, Chord Energy’s share price of $135.34 sits against a year to date share price return of 42.94% and a 1 year total shareholder return of 33.66%, while the 30 day share price return has...

Agnico Eagle Mines (AEM) is back in focus after securing approval to renew its share buyback program, allowing repurchases of up to 25,024,469 common shares through May 2027, with all repurchased stock canceled. See our latest analysis for Agnico Eagle Mines. Agnico Eagle’s share price has been under pressure recently, with a 30 day share price return of down 9.81% and a 90 day share price return of down 22.61%. However, its 1 year total shareholder return of 31.90% and very large 3 year and...

Recent coverage of Taysha Gene Therapies (TSHA) focuses on clinical data for TSHA-102 in Rett syndrome, highlighting a reported 100% responder rate and clean safety profile, as well as preparations for commercial-scale manufacturing and future regulatory filings. See our latest analysis for Taysha Gene Therapies. At a recent share price of US$5.71, Taysha Gene Therapies has shown a 1 day share price return of 2.33% and a 90 day share price return of 26.05%. The 1 year total shareholder return...

Rezolve AI (RZLV) is back in focus after its board outlined plans for a US$300 million share repurchase program linked to a capital reduction, along with new commercial partnerships and leadership changes. See our latest analysis for Rezolve AI. The stock has drawn fresh attention after the US$300 million buyback announcement, a global resale deal with Tata Consultancy Services and peer reviewed validation of its TraceWare technology. The 7 day share price return of 16.52% contrasts with a...

In the past week, analysts have projected that Jabil will report higher third‑quarter earnings per share and revenue year over year when it releases results on June 17, 2026, with growth expected in areas such as Intelligent Infrastructure and Regulated Industries but softness in Connected Living and Digital Commerce. These expectations, alongside a recent quarterly dividend and attention to segment‑level shifts, highlight how investors are weighing Jabil’s earnings power against signs like...

Some Gen Digital Inc. ( NASDAQ:GEN ) shareholders may be a little concerned to see that the Director, Ondrej Vlcek...

Intellia Therapeutics recently reported additional positive results from its Phase 3 HAELO trial of gene-editing therapy lonvo-z for hereditary angioedema at the EAACI 2026 Congress in Istanbul, showing strong reductions in attack rates and high proportions of attack- and therapy-free patients. The company has also begun a rolling biologics license application with the FDA for lonvo-z, signaling that its first potential commercial gene-editing therapy may be moving closer to the market and...

Earlier this week, nVent Electric plc appointed Nitin Jain as Executive Vice President and Chief Strategy Officer and Joe Stark as Executive Vice President and Chief Revenue Officer, both reporting directly to Chair and CEO Beth Wozniak to oversee global strategy, acquisitions, and sales. The move concentrates decision-making over capital deployment and large deals in a tight leadership group, signaling a clear push to align corporate strategy, acquisition activity, and global revenue...

Capital Southwest (CSWC) drew fresh attention after reporting a softer Q1, with revenue growing 10.2% year over year but landing 7% below analyst estimates, alongside new investments, capital raising and dividend declarations. See our latest analysis for Capital Southwest. At a share price of $23.54, Capital Southwest has seen momentum pick up recently, with a 10.1% 90 day share price return and a 26.4% 1 year total shareholder return hinting at improving sentiment despite the softer Q1...

CVS Health stock moves and recent performance With no single headline event driving CVS Health (CVS) today, the stock's recent performance and business profile give you most of the context for thinking about its role in a diversified portfolio. See our latest analysis for CVS Health. The recent 1-day share price return of 1.47% and 7-day return of 6.29% build on a 90-day share price return of 34.44%, while the 1-year total shareholder return of 56.67% points to momentum that has been strong...

The successful SpaceX IPO, with SPCX shares jumping 19% on debut and a market cap of US$1.77b, has reminded investors how powerful enthusiasm for growth-oriented tech can be when fresh stories hit the market. Broader US indices, including the Dow, S&P 500, and Nasdaq, also gained as risk appetite picked up around the listing and its ambitious AI-in-space plans. For you, the key question is which existing growth stocks could be helped by this renewed interest in high-growth tech. Below, you...

Newmont (NEM) has moved back into focus as investors look ahead to an earnings report that is expected to show strong year over year growth in earnings and revenue, supported by solid cash generation and share buybacks. See our latest analysis for Newmont. The stock has recently bounced, with a 1 day share price return of 2.71%, but a 30 day share price return down 8.10% and a 90 day share price return down 9.04%. At the same time, the 1 year total shareholder return of 74.95% and 3 year...

Why Clear Channel Outdoor Holdings is on investors’ radar today Clear Channel Outdoor Holdings (CCO) has drawn investor attention after recent trading reflected modest short term gains, prompting closer scrutiny of how its current valuation lines up with its fundamentals and risk profile. See our latest analysis for Clear Channel Outdoor Holdings. At a share price of $2.41, Clear Channel Outdoor Holdings has seen steady share price momentum, with a 13.68% year to date share price return and a...

Recent commentary on TransDigm Group highlights that its core aircraft components business has delivered strong organic revenue growth, expanding profitability, and robust free cash flow generation, underpinned by high-margin aftermarket sales of mission-critical parts. An interesting nuance is that this operational strength coexists with recent insider share sales, suggesting executives are realizing gains even as external assessments still score the company highly on profitability and...

Recent performance snapshot Mercury Systems (MRCY) has drawn fresh attention after a strong run in the stock, with gains over the past year and multi year period prompting investors to reassess the defense electronics specialist. See our latest analysis for Mercury Systems. The recent move to a share price of $120.30 caps a strong run, with a 30 day share price return of 30.72% and a 1 year total shareholder return of 127.07%, indicating continued momentum rather than a short lived bounce. If...

MACOM Technology Solutions Holdings (MTSI) has drawn fresh attention after unveiling new RF and optical components for satellite communications, including power and low noise amplifiers, at the International Microwave Symposium in Boston. See our latest analysis for MACOM Technology Solutions Holdings. Recent product news has arrived as momentum in the stock has been strong, with a 1-day share price return of 1.36%, a 90-day share price return of 68.89%, and a 1-year total shareholder return...

What Brown & Brown’s recent performance signals for investors Brown & Brown (BRO) has not been in the headlines for a single defining event, but recent share performance and current fundamentals give you several concrete data points to assess the insurance broker’s risk and return profile. The stock closed at US$59.99, with the month return at 6.6% and the past 3 months showing a decline of 13.3%. Over the past year, total return is down 43.2%, while the 3 year total return is down 7.5% and...

Global trade is picking up again, with AI hardware, semiconductors, and advanced electronics right at the center of that shift. For investors, this news event is a cue to look closely at companies that sit along these supply chains, from chip manufacturers to component suppliers and equipment makers. Some stocks could benefit from stronger export trends, inventory rebuilding, and supply chain expansion across Asia, while others may face pressure from policy risks and competition. This article...